Letters to the editor: Second-line M-VAC therapy in patients previously treated with the M-VAC regimen for metastatic urothelial cancer
- 1 November 1993
- journal article
- research article
- Published by Elsevier in Annals of Oncology
- Vol. 4 (9) , 793-794
- https://doi.org/10.1093/oxfordjournals.annonc.a058668
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced carcinoma of the bladderEuropean Journal of Cancer and Clinical Oncology, 1991
- Prognostic factors for survival of patients with advanced urothelial tumors treated with methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapyCancer, 1991
- Escalated Therapy for Refractory Urothelial Tumors: Methotrexate- Vinblastine-Doxorubicin- Cisplatin Plus Unglycosylated Recombinant Human Granulocyte-macrophage Colony-Stimulating FactorJNCI Journal of the National Cancer Institute, 1990